Today: 20 November 2025
Subscribe
Browse Category

Company News News 2 November 2025 - 6 November 2025

Vistra (VST) Q3 2025: $652M Profit, 2026 EBITDA Outlook Raised to $6.8–$7.6B; Board Adds $1B Buyback

Vistra (VST) Q3 2025: $652M Profit, 2026 EBITDA Outlook Raised to $6.8–$7.6B; Board Adds $1B Buyback

What Vistra reported today Vistra posted third‑quarter 2025 GAAP net income of $652 million and Ongoing Operations Adjusted EBITDA of $1.581 billion. Management said the year‑over‑year decline in GAAP profit primarily reflects lower unrealized mark‑to‑market gains on hedging positions and the Martin Lake Unit 1 outage, partially offset by recognition of nuclear production tax credit revenue and firmer capacity prices. PR Newswire Top line performance came in at $4.97 billion, about 21% lower than the prior year’s quarter. Investors Guidance: a bigger 2026, tighter 2025 On the call and in media briefings, Vistra linked the stronger 2026 outlook to expanding
6 November 2025
 ·  ·  ·  ·  · 
ConocoPhillips (COP) beats Q3, hikes dividend 8%, lifts 2025 output; Willow budget raised to up to $9B — Nov. 6, 2025

ConocoPhillips (COP) beats Q3, hikes dividend 8%, lifts 2025 output; Willow budget raised to up to $9B — Nov. 6, 2025

ConocoPhillips (NYSE: COP) delivered a news‑packed earnings day: the U.S. independent beat third‑quarter profit expectations, raised its full‑year production guidance, increased its quarterly dividend by 8% to $0.84, and updated the cost outlook for its Willow project in Alaska to $8.5–$9.0 billion. Management also released preliminary 2026 guidance with lower planned capital and operating costs and flat‑to‑modest production growth. ConocoPhillips The quick take By the numbers (Q3 2025) What changed today — and why it matters Earnings beat and stronger 2025 outlook. ConocoPhillips outpaced expectations on adjusted profit thanks to higher production and lower operating costs. The company also lifted
6 November 2025
 ·  ·  ·  ·  · 
Rivian’s Wild 2025 Ride: Stock Price Update, Q3 Surprises, EV Rivalry & Future Forecasts

Rivian (RIVN) Tops Q3: $1.56B Revenue, $416M Software & New ‘Mind Robotics’ Spinoff — Nov. 6, 2025

Rivian Automotive, Inc. (NASDAQ: RIVN) stayed in the spotlight today, Nov. 6, 2025, as investors digested a stronger‑than‑expected third quarter, a surprise jump in software revenue, and a new industrial AI spinoff. Shares held most of yesterday’s rally after the beat, while pre‑market trade showed slight consolidation. Reuters+1 Key takeaways (Nov. 6, 2025) What’s new today (Nov. 6) 1) Mind Robotics gets more oxygenFollow‑up coverage today underscores Rivian’s move beyond vehicles. In its Q3 materials, the company disclosed the launch of Mind Robotics—a separate venture focused on industrial AI systems—with about $110–115 million in outside capital. Trade outlet MarkLines dated
6 November 2025
 ·  ·  ·  ·  · 
Nebius (NBIS) Stock Rockets 350% on AI Boom – Bubble or Breakout? Experts Weigh In

‘Vineland ramp’ or bust? Nebius’ Q3 countdown, Microsoft mega‑deal and stock‑split buzz — what investors need to know now

The big picture Nebius — the Amsterdam‑based AI‑infrastructure company created from Yandex’s non‑Russian assets — has become one of 2025’s most closely watched “neocloud” names. Its Nov. 11 Q3 print arrives amid a volatile week for the stock, but also against a backdrop of blockbuster contracts, aggressive capacity additions, and rising questions about how the AI data‑center boom is being financed across the industry. nebius.com+2Reuters+2 Why Nov. 11 matters Two catalysts frame Tuesday’s report: Nebius itself set expectations in its calendar update: Q3 results before the bell on Tuesday, Nov. 11, followed by the usual call. nebius.com Today’s market check
5 November 2025
 ·  ·  ·  · 
ADM Stock Plummets on Outlook Cut – Key Facts and What’s Next

ADM Stock Plummets on Outlook Cut – Key Facts and What’s Next

Overview of ADM’s Business Model and Operations Archer-Daniels-Midland is one of the world’s largest agricultural commodity processors and traders, with a vast global footprint built over 120+ years highperformr.ai. The company buys crops like corn, soybeans, wheat, and cocoa from farmers (known as origination), then processes these raw commodities into a wide range of products. ADM’s operations “connect the harvest to the home,” producing everything from food ingredients (e.g. sweeteners, vegetable oils, plant proteins, flavors) to animal feeds, biofuels like ethanol and biodiesel, and other industrial commodities highperformr.ai. ADM’s scale is enormous – the company operates in over 70 countries
4 November 2025
 ·  ·  ·  ·  · 
New Fortress Energy Seeks U.K. Lifeline to Dodge Bankruptcy – Shares Crash as $9 B Debt Weighs

New Fortress Energy’s Wild Ride: 90% Crash, Debt Drama & a Surprise Rally – What’s Next for NFE Stock?

Current Stock Price & Recent Performance Illustration: New Fortress Energy’s logo displayed on a smartphone. NFE stock has whipsawed dramatically in 2025, collapsing to penny-stock levels before a recent rebound. As of November 4, 2025, New Fortress Energy’s stock is trading around the mid-$1 range, down over 90% from January. The shares closed at $1.18 on Nov 3 (near record lows) and then jumped to ~$1.57 in pre-market trading on Nov 4 marketbeat.com. This ~30% overnight spike came on the heels of an intense selloff – a microcosm of the stock’s extreme volatility lately. Over the past week, NFE swung
4 November 2025
 ·  ·  ·  · 
PTL Limited (PTLE) Stock Soars on Surprise Profit Amid Delisting Risks – Key Facts & Outlook

PTL Limited (PTLE) Stock Soars on Surprise Profit Amid Delisting Risks – Key Facts & Outlook

Recent News – Earnings Spark a Relief Rally PTL Limited’s latest financial report (released Nov 3, 2025) revealed an unexpected profit, igniting a sharp rally in its beaten-down stock. The Hong Kong–based marine fuel logistics company announced unaudited results for the six months ended June 30, 2025, highlighting a net income of $1.21 million, up from just $0.32 M in the same period a year prior globenewswire.com. This 277% profit jump came despite revenue falling 13.4% to $43.56 M in H1 2025 globenewswire.com. Gross profit was thin at $0.55 M (1.3% margin), down from $1.14 M (2.3% margin) a year ago globenewswire.com, reflecting razor-thin margins
4 November 2025
 ·  ·  ·  ·  · 
IREN Stock Today (Sept 26, 2025): AI Cloud Moonshot Meets Wall Street Reality Check—Is the Rally Just Pausing or Running Out of Fuel?

Iren S.p.A. Stock Soars in 2025 Rally – Analysts Pump the Brakes Ahead of Big Strategic Reveal

Current Stock Performance (Early Nov 2025) Iren’s stock is trading near its highs for the year as we enter November. On November 3, 2025, shares closed around €2.54 on the Borsa Italiana, essentially flat on the day stockinvest.us. Midday on Nov. 4, the price hovered about €2.53, keeping the market cap near €3.3 billion reuters.com. This marks a dramatic climb of over 30% year-to-date finanza.repubblica.it – a sizable outperformance versus the broader Italian market. For context, Iren’s stock began the year around the mid-€1.90s and has rallied amid strengthening financial results and a rebound in utility sector sentiment. Even after a
4 November 2025
 ·  ·  ·  · 
Hims & Hers Health Stock Skyrockets amid Weight-Loss Mania – But FDA Scrutiny Looms

Hims & Hers (HIMS) Stock Soars on Subscriber Surge and GLP-1 Deal Buzz – Nov 2025 Update

Current Stock Price (Nov 3, 2025) Hims & Hers Health’s stock (NYSE: HIMS) closed on Nov 3, 2025 at $44.39, down about 2.3% for the day stockanalysis.com. This modest dip came amid a broader mixed market and ahead of the company’s earnings release after the bell. However, immediately following its Q3 earnings report that evening, HIMS shares jumped roughly 6% in after-hours trading, climbing to around $46.70 investing.com. The post-market pop was driven by upbeat revenue and subscriber numbers (more on that below), signaling renewed investor optimism. Even after recent volatility, HIMS stock has had a stellar year. At ~$44–$47,
4 November 2025
 ·  ·  ·  ·  · 
Rani Therapeutics (RANI) Stock Skyrockets on Biotech Breakthrough: Inside the Surge and What’s Next

Rani Therapeutics (RANI) Stock Skyrockets on Biotech Breakthrough: Inside the Surge and What’s Next

RANI Stock Performance: From Penny Stock to Momentum Rocket Rani Therapeutics’ stock price has been on a tear in late 2025, turning heads in the biotech investing community. After languishing under $1 for most of the year, RANI exploded upward in October. It closed on Oct 31 at $2.20, up +51.7% in one day finviz.com on massive volume (~61 million shares vs ~15 million average finviz.com). In fact, over the past month RANI has climbed about 335% finviz.com. Just a few weeks ago in early October it was trading around 50–60 cents; by the first week of November it’s oscillating
3 November 2025
 ·  ·  ·  ·  · 
MSP Recovery (MSPR) Stock Skyrockets 100% Amid Delisting Drama – What’s Next for This Troubled Company?

MSP Recovery (MSPR) Stock Skyrockets 100% Amid Delisting Drama – What’s Next for This Troubled Company?

In short: MSP Recovery’s stock is trading at mere pennies after a spectacular rise-and-fall on Nov 3. The company is fighting for survival – juggling emergency financings, a looming Nasdaq delisting, and ongoing legal battles – all while attempting to transform its fortunes in the healthcare reimbursement industry. Company Overview: Business Model & Financials Business Model: MSP Recovery, Inc. is a 2014-founded Miami-based company that aims to recover reimbursements from Medicare, Medicaid, and other insurers on behalf of healthcare payers tipranks.com. Under the Medicare Secondary Payer (MSP) Act, if a private insurer should have paid a claim that Medicare/Medicaid covered,
3 November 2025
 ·  ·  ·  · 
Occidental Petroleum’s Big Deal with Berkshire & What’s Ahead: Stock Performance, News and Analysts’ View (October 2 2025)

Occidental Petroleum Primed for Action Monday: Berkshire Deal, Oil Trends & Analyst Outlook Unpacked

Latest Stock Price & Premarket Movement Friday’s close at $41.20 stockanalysis.com left Occidental near the lower end of its recent trading range (roughly $40–46 in the past month chartmill.com). In technical terms, the stock is hovering just above a chart support zone around $40.8–41.1 chartmill.com. On that basis, Monday’s premarket session showed OXY little changed, following a flat oil-futures overnight. By contrast, broad markets (Dow, S&P) were expected to open modestly higher on the heels of the Fed decision and mixed economic cues. Given OXY’s recent vol and current price, any meaningful gap either way could be triggered by oil
2 November 2025
 ·  ·  ·  ·  · 
1 … 8 9 10 11 12 … 15
Go toTop